Cargando…
Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance
Autores principales: | Åbacka, Hannah, Hansen, Jesper S., Huang, Peng, Venskutonytė, Raminta, Hyrenius-Wittsten, Axel, Poli, Giulio, Tuccinardi, Tiziano, Granchi, Carlotta, Minutolo, Filippo, Hagström-Andersson, Anna K., Lindkvist-Petersson, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018118/ https://www.ncbi.nlm.nih.gov/pubmed/32554563 http://dx.doi.org/10.3324/haematol.2020.246843 |
Ejemplares similares
-
The intracellular helical bundle of human glucose transporter GLUT4 is important for complex formation with ASPL
por: Huang, Peng, et al.
Publicado: (2023) -
Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors
por: Poli, Giulio, et al.
Publicado: (2017) -
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors
por: Granchi, Carlotta, et al.
Publicado: (2017) -
Application of MM-PBSA Methods in Virtual Screening
por: Poli, Giulio, et al.
Publicado: (2020) -
Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
por: Jha, Vibhu, et al.
Publicado: (2020)